Yarrow Bioscience Inc YARW
14.70 USD -3.67 (-19.98%)
Nov 4, 2026, 2:39 PM EST
14.70 Day range 19.00
14.70 52-week range 46.95
- YTD
- -49.31%
- 1 year
- -10.37%
- Market cap
- 136.77M
- YTD return
- -49.31%
- 1-year return
- -10.37%
- Volume
- 55.86K
- Avg volume
- 124.08K
- Open
- 18.20
- Previous close
- 18.37
- Day's range
- 14.70 – 19.00
- 52-week range
- 14.70 – 46.95
6M -18.11 (-54.38%)
Financials — quick view
YARW Revenue — quarterly 97.00K
YARW Net income — quarterly -3.01M
YARW EPS — quarterly -3.51
News
Yarrow Bioscience Announces Participation in November Investor Events 
Contrasting Yarrow Bioscience (NASDAQ:YARW) and Atara Biotherapeutics (NASDAQ:ATRA) 
Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares 
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering 
Yarrow Bioscience Launches Underwritten Public Offering To Fund Pipeline Development And Corporate Operations; No Terms Disclosed 
Yarrow Bioscience Announces Proposed Underwritten Public Offering 
Yarrow Bioscience Q2 EPS $(2.14) Misses $(0.22) Estimate 
Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update 
This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday 
BTIG Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $58
Your note
Sign in to keep a note on YARW — it syncs with the Stock Master app.